Filament Health Corp. operates as a clinical-stage natural psychedelic drug development company. The company propagates psychedelic plants and fungi; conducts genetic research; develops manufacturing technology; generates intellectual property; conducts in-house trials; and distributes drug candidates to drug developers, researchers, and other licensed parties. Filament Health Corp. is headquartered in Burnaby, Canada.
Stock data | 2024 | Change |
---|---|---|
Price | $0.01833944648216072 | N/A |
Market Cap | $3.72M | N/A |
Shares Outstanding | 202.73M | N/A |
Employees | 11.00 | N/A |